Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Arm, Prospective, Open Label, Multicenter Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems in the Visualization of Lymphatic Vessels and Lymph Nodes During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Subjects With Breast Cancer

NCT03200704 is registered in ClinicalTrials.gov with Novadaq Technologies ULC, now a part of Stryker as lead sponsor.

NCT NCT03200704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03200704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Arm, Prospective, Open Label, Multicenter Study Assessing the Safety and Effectiveness of IC2000 and SPY Fluorescence Imaging Systems in the Visualization of Lymphatic Vessels and Lymph Nodes During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Subjects With Breast Cancer
Lead sponsor
Novadaq Technologies ULC, now a part of Stryker
Phase
Phase 3
Overall status
Completed
Start date
January 4, 2019
Completion date
September 28, 2020
Enrollment
152 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymph node mapping, sentinel lymph node biopsy